FIELD: medicine; chemistry.
SUBSTANCE: invention relates to chemistry and medicine, namely to use of peptide Ac-His-Ala-Glu-Glu-NH2 with N-terminal acetyl group and C-terminal amide group (HAEE) or its pharmaceutically acceptable salts or its pharmaceutically acceptable complexes with metal cations to restore physiologically normal concentration of endogenous HAEE in human blood.
EFFECT: invention provides the possibility of restoring the physiologically normal concentration of endogenous HAEE in the blood in diseases or disorders of human health associated with neuroinflammation and characterized by a drop in the level of endogenous HAEE in blood compared to the norm.
3 cl, 1 dwg, 6 tbl, 4 ex
Authors
Dates
2024-09-16—Published
2024-06-11—Filed